Results 61 to 70 of about 1,943,371 (81)

Heavy tail distribution and Deuterium excess for drought assessment case of Djelfa- watershed (Algeria)

Theoretical and Applied Climatology
S. E. Ali Rahmani, B. Chibane, A. Boucefiane, F. Hallouz, Malika Bentchakal   +4 more
semanticscholar   +1 more source

Features of “ET plus” correlate with age and tremor duration: “ET plus” may be a disease stage rather than a subtype of essential tremor

Parkinsonism and Related Disorders, 2021
Stephanie Cosentino, Edward Huey
exaly  

An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma

Cancer Cell, 2023
Rui-Hua Xu, Zhixiang Zuo, Yan-Xing Chen   +2 more
exaly  

Rainfall Data Analysis in Kerian River Basin Using HYFRAN-PLUS Model, Malaysia

Nor Faiza Abd Rahman, Yannick Mondelly, Vin Cent Tai, Munira Mohammad, Mohamad Shakri Mohmad Shariff, Khairi Khalid, Ee Li Siew   +6 more
openaire   +1 more source

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Lancet, The, 2001
Mitchell Shiffman, Michael Peter Manns, Zachary Goodman   +2 more
exaly  

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Lancet, The, 2013
Dieter Hoelzer, Mathias J Rummel, Gerhard Heil   +2 more
exaly  

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2016
Conghua Xie, Jianji Pan, Jianping Xiong   +2 more
exaly  

Randomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041)

Annals of Oncology, 2011
Daisuke Aoki, N Yaegashi, I Konishi
exaly  

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Annals of Oncology, 2019
Chigusa Morizane, S Nakamori, N Okano
exaly  

CEPHALOTHIN PLUS AN AMINOGLYCOSIDE IS MORE NEPHROTOXIC THAN METHICILLIN PLUS AN AMINOGLYCOSIDE

Lancet, The, 1978
Jerrold Ellner, P S Lietman, J J Lipsky
exaly